19 September 2022 : Clinical Research
Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
DOI: 10.12659/MSM.937757
Med Sci Monit 2022; 28:e937757
Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST
19 September 2022 : Clinical Research
DOI: 10.12659/MSM.937757
Med Sci Monit 2022; 28:e937757
We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.